APFED Expands Patient Education Resources with Spanish Translations

New materials empower Spanish-speaking patients and caregivers to manage eosinophil-associated diseases

(Atlanta, GA)—The American Partnership for Eosinophilic Disorders (APFED) is thrilled to announce the availability of patient education materials in Spanish, further enhancing our commitment to providing accessible and culturally-sensitive healthcare information to our diverse patient community.

APFED recognizes the importance of meeting the needs of a growing population of Spanish-speaking individuals who seek information about eosinophil-associated diseases. The introduction of Spanish patient education materials marks a significant step forward in ensuring that Spanish-speaking patients have access to comprehensive and understandable resources about these diseases.

Eosinophil-associated diseases are chronic inflammatory conditions characterized by elevated levels of eosinophils (a type of white blood cell) in one or more specific areas of the body. The elevated number of eosinophils cause inflammation and damage to tissues and organs. These conditions require lifelong medical care and symptoms can be debilitating.

The newly available Spanish patient education materials include a webpage entitled, “What is an Eosinophilic Disease?” that includes information about eosinophil-associated diseases and an educational video and infographic. There is an additional webpage in Spanish dedicated to eosinophilic esophagitis (EoE) with information about EoE, as well as links to a brochure, resource guide, patient participation in research, and an opportunity for Spanish-speaking visitors to share their experiences.

“APFED is committed to providing the highest level of information and support to everyone in our community,” shared APFED’s Executive Director Mary Jo Strobel. “We believe that access to healthcare information is a fundamental right, and our new Spanish patient education materials are another example of our dedication to making healthcare resources available to all, regardless of language or background.”

APFED developed these resources to empower Spanish-speaking patients and caregivers to take an active role in managing eosinophil-associated diseases and making informed decisions about care. This translation was generously supported by Abbott, Sanofi Regeneron, and Global Allergy & Airways Patient Platform.

###
About the American Partnership for Eosinophilic Disorders (APFED)
The American Partnership for Eosinophilic Disorders (APFED) is a non-profit organization whose mission is to passionately embrace, support, and improve the lives of patients and families affected by eosinophil-associated diseases through education and awareness, research, support, and advocacy.  https://www.APFED.org